(VIANEWS) – Casella Waste Systems (CWST), Quanta Services (PWR), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Casella Waste Systems (CWST)
26.5% sales growth and 5.47% return on equity
Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States. It offers resource management services primarily in the areas of solid waste collection and disposal, transfer, recycling, and organics services to residential, commercial, municipal, and industrial customers. The company provides a range of non-hazardous solid waste services, including collections, transfer stations, and disposal facilities. It also markets recyclable metals, aluminum, plastics, and paper and corrugated cardboard that are processed at its facilities, as well as recyclables purchased from third parties. In addition, the company is involved in commodity brokerage operations. As of April 15, 2021, it owned and/or operated 46 solid waste collection operations, 58 transfer stations, 20 recycling facilities, 8 Subtitle D landfills, 4 landfill gas-to-energy facilities, and 1 landfill permitted to accept construction and demolition materials. The company was founded in 1975 and is headquartered in Rutland, Vermont.
Earnings Per Share
As for profitability, Casella Waste Systems has a trailing twelve months EPS of $0.77.
PE Ratio
Casella Waste Systems has a trailing twelve months price to earnings ratio of 100.31. Meaning, the purchaser of the share is investing $100.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.47%.
Sales Growth
Casella Waste Systems’s sales growth is 34.9% for the present quarter and 26.5% for the next.
2. Quanta Services (PWR)
15.5% sales growth and 10.93% return on equity
Quanta Services, Inc. provides specialty contracting services in the United States, Canada, Australia, Latin America, and internationally. Its Electric Power Infrastructure Services segment designs, installs, upgrades, repairs, and maintains electric power transmission and distribution infrastructure, and substation facilities, as well as provides other engineering and technical services; designs, installs, maintains, and repairs commercial and industrial wiring; and operates a postsecondary educational institution. It also offers emergency restoration services, including the repair of infrastructure damaged by inclement weather; installation, maintenance, and upgrade of electric power infrastructure; and installation of smart grid technologies on electric power networks. In addition, this segment provides services related to development of solar, wind, and various natural gas generation facilities, as well as related switchyards and transmission infrastructure; and construction of electric power generation facilities. The company's Pipeline and Industrial Infrastructure Services segment designs, installs, repairs, and maintains pipeline transmission and distribution systems, gathering systems, production systems, storage systems, and compressor and pump stations, as well as offers related trenching, directional boring, and mechanized welding services; and designs, installs, and maintains fueling systems, and water and sewer infrastructure. This segment also provides pipeline protection, integrity testing, and rehabilitation and replacement, as well as pipeline support systems, and related structures and facilities fabrication services; and high-pressure and critical-path turnaround, electrical, piping, fabrication, and storage tank services. It serves electric power, energy, and communications companies, as well as commercial, industrial, and governmental entities. The company was founded in 1997 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Quanta Services has a trailing twelve months EPS of $3.91.
PE Ratio
Quanta Services has a trailing twelve months price to earnings ratio of 46.18. Meaning, the purchaser of the share is investing $46.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
3. Edwards Lifesciences (EW)
14% sales growth and 22.4% return on equity
Some other top-ranked stocks in the broader medical space that have announced quarterly results are Abbott Laboratories (ABT Quick QuoteABT – Free Report) , Elevance Health, Inc. (ELV Quick QuoteELV – Free Report) and Edwards Lifesciences (EW Quick QuoteEW – Free Report) .
Some better-ranked stocks in the broader medical space that have announced quarterly results are Abbott Laboratories (ABT Quick QuoteABT – Free Report) , Elevance Health, Inc. (ELV Quick QuoteELV – Free Report) and Edwards Lifesciences (EW Quick QuoteEW – Free Report) .
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.26.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 28.36. Meaning, the purchaser of the share is investing $28.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Edwards Lifesciences’s EBITDA is 126.68.
Volume
Today’s last reported volume for Edwards Lifesciences is 5994490 which is 55.75% above its average volume of 3848580.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 5.66B for the twelve trailing months.
Previous days news about Edwards Lifesciences(EW)
- According to Zacks on Wednesday, 25 October, "Edwards Lifesciences: Similar to the last reported quarter, Edwards Lifesciences is likely to have gained from its patient-focused innovation strategy. ", "Medical device companies like Boston Scientific (BSX Quick QuoteBSX – Free Report) , BioRad Laboratories (BIO Quick QuoteBIO – Free Report) , Edwards Lifesciences (EW Quick QuoteEW – Free Report) and Labcorp (LH Quick QuoteLH – Free Report) are likely to have been influenced by these abovementioned factors in the third quarter."
- Edwards lifesciences (ew) Q3 earnings match estimates. According to Zacks on Wednesday, 25 October, "While Edwards Lifesciences has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Edwards lifesciences (ew) reports Q3 earnings: what key metrics have to say. According to Zacks on Wednesday, 25 October, "For the quarter ended September 2023, Edwards Lifesciences (EW Quick QuoteEW – Free Report) reported revenue of $1.48 billion, up 12.3% over the same period last year. ", "Here is how Edwards Lifesciences performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
4. Tetra Technologies (TTI)
11.2% sales growth and 18.43% return on equity
TETRA Technologies, Inc., together with its subsidiaries, operates as an energy services and solutions company. It operates through two segments, Completion Fluids & Products Division and Water & Flowback Services. The Completion Fluids & Products segment manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa. This segment also markets liquid and dry calcium chloride products; and TETRA PureFlow ultra-pure zinc bromide to battery technology companies. The Water & Flowback Services segment provides water management services for onshore oil and gas operators. This segment also offers frac flowback, production well testing, and other associated services in oil and gas producing regions in the United States and Mexico, as well as in various basins in Latin America, Africa, Europe, and the Middle East. The company was incorporated in 1981 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, Tetra Technologies has a trailing twelve months EPS of $0.17.
PE Ratio
Tetra Technologies has a trailing twelve months price to earnings ratio of 35.29. Meaning, the purchaser of the share is investing $35.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.43%.
Volume
Today’s last reported volume for Tetra Technologies is 1278830 which is 33.39% below its average volume of 1920060.
Sales Growth
Tetra Technologies’s sales growth is 16.8% for the current quarter and 11.2% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tetra Technologies’s EBITDA is 17.47.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 604.13M for the twelve trailing months.
5. Sapiens International Corporation N.V. (SPNS)
9.7% sales growth and 14.19% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $1.02.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 25.12. Meaning, the purchaser of the share is investing $25.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 14, 2023, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 1.96%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 491.48M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 13.3% and 6.3%, respectively.
Moving Average
Sapiens International Corporation N.V.’s value is way under its 50-day moving average of $28.95 and higher than its 200-day moving average of $24.65.
6. United Airlines (UAL)
8.2% sales growth and 41.61% return on equity
United Airlines Holdings, Inc., through its subsidiaries, provides air transportation services in North America, Asia, Europe, Africa, the Pacific, the Middle East, and Latin America. The company transports people and cargo through its mainline and regional fleets. It also offers catering, ground handling, training, and maintenance services for third parties. The company was formerly known as United Continental Holdings, Inc. and changed its name to United Airlines Holdings, Inc. in June 2019. United Airlines Holdings, Inc. was incorporated in 1968 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, United Airlines has a trailing twelve months EPS of $8.64.
PE Ratio
United Airlines has a trailing twelve months price to earnings ratio of 4.06. Meaning, the purchaser of the share is investing $4.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.61%.
Volume
Today’s last reported volume for United Airlines is 4316110 which is 34.28% below its average volume of 6568160.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 30.1% and positive 85.7% for the next.
7. Surgery Partners (SGRY)
6.5% sales growth and 3.08% return on equity
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Earnings Per Share
As for profitability, Surgery Partners has a trailing twelve months EPS of $-0.57.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.08%.
Sales Growth
Surgery Partners’s sales growth is 5.9% for the current quarter and 6.5% for the next.
8. Washington Federal (WAFD)
5.7% sales growth and 10.95% return on equity
Washington Federal, Inc. operates as the bank holding company for Washington Federal Bank, National Association that provides lending, depository, insurance, and other banking services in the United States. The company accepts deposit products, including business and personal checking accounts, and term certificates of deposit, as well as money market accounts and passbook savings accounts. It also provides single-family residential, construction, land acquisition and development, consumer lot, multi-family residential, commercial and industrial, commercial real estate, home equity, and consumer loans. In addition, the company offers insurance brokerage services, such as individual and business insurance policies to customers and general public; holds and markets real estate properties; mobile and internet banking services; debit and credit cards; and acts as trustee. It serves consumers, mid-sized and large businesses, and owners and developers of commercial real estate. As of September 30, 2020, the company had 234 branches located in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, and Texas. Washington Federal, Inc. was founded in 1917 and is headquartered in Seattle, Washington.
Earnings Per Share
As for profitability, Washington Federal has a trailing twelve months EPS of $4.07.
PE Ratio
Washington Federal has a trailing twelve months price to earnings ratio of 6.15. Meaning, the purchaser of the share is investing $6.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.
Yearly Top and Bottom Value
Washington Federal’s stock is valued at $25.05 at 16:22 EST, way under its 52-week high of $39.17 and higher than its 52-week low of $23.90.
